Diabetic oncopathy--one more yet another deadly diabetic complication!
作者信息
Balasubramanyam M
机构信息
Madras Diabetes Research Foundation (MDRF) No. 4 Conran Smith Road, Gopalapuram Chennai 600 086, India.
出版信息
Indian J Med Res. 2014 Jul;140(1):15-8.
Abstract
摘要
相似文献
1
Diabetic oncopathy--one more yet another deadly diabetic complication!糖尿病性肿瘤病变——又一种致命的糖尿病并发症！
Indian J Med Res. 2014 Jul;140(1):15-8.
2
Diabetes and cancer.糖尿病和癌症。
QJM. 2010 Dec;103(12):905-15. doi: 10.1093/qjmed/hcq149. Epub 2010 Aug 25.
3
Illuminating the diabetes-cancer link.揭示糖尿病与癌症之间的联系。
J Natl Cancer Inst. 2012 Jul 18;104(14):1048-50. doi: 10.1093/jnci/djs322. Epub 2012 Jul 9.
4
[Diabetes and cancer risk: oncologic considerations].[糖尿病与癌症风险：肿瘤学考量]
Orv Hetil. 2011 Jul 17;152(29):1144-55. doi: 10.1556/OH.2011.29158.
5
[New clinical data with metformin therapy in patients with diabetes mellitus].[二甲双胍治疗糖尿病患者的新临床数据]
Orv Hetil. 2010 Dec 5;151(49):2025-30. doi: 10.1556/OH.2010.29005.
6
[112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Diabetes and Its Treatment and Cancer].
Nihon Naika Gakkai Zasshi. 2015 Sep;104(9):1897-1900.
7
Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview.二甲双胍在2型糖尿病及其相关并发症中的作用机制：综述
Mini Rev Med Chem. 2008 Nov;8(13):1343-54. doi: 10.2174/138955708786369546.
8
Diabetes and cancer: a 2013 synopsis.糖尿病与癌症：2013年综述
Diabetes Metab Syndr. 2013 Oct-Dec;7(4):247-50. doi: 10.1016/j.dsx.2013.08.001. Epub 2013 Sep 12.
9
Switching a hyperinsulinemic patient from insulin to oral hypoglycemics.将一名高胰岛素血症患者从胰岛素治疗转换为口服降糖药治疗。
JAAPA. 2012 Dec;25(12):48, 50, 52-3. doi: 10.1097/01720610-201212000-00010.
10
Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study.在一个大型以色列健康维护组织中，糖尿病患者恶性肿瘤的发病率与治疗方式的相关性：一项历史性队列研究。
Metabolism. 2011 Oct;60(10):1379-85. doi: 10.1016/j.metabol.2011.05.002. Epub 2011 Jun 21.
引用本文的文献
1
Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease.2型糖尿病合并代谢功能障碍相关脂肪性肝病患者I级左心室舒张功能障碍的新型生物标志物
J Clin Med. 2024 Oct 2;13(19):5901. doi: 10.3390/jcm13195901.
2
Diabetes Mellitus and Other Predictors for the Successful Treatment of Metastatic Colorectal Cancer: A Retrospective Study.糖尿病及其它预测转移性结直肠癌成功治疗的因素：一项回顾性研究。
Medicina (Kaunas). 2022 Jun 29;58(7):872. doi: 10.3390/medicina58070872.
本文引用的文献
1
Human insulin does not increase bladder cancer risk.人胰岛素不会增加患膀胱癌的风险。
PLoS One. 2014 Jan 20;9(1):e86517. doi: 10.1371/journal.pone.0086517. eCollection 2014.
2
The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.二甲双胍对合并糖尿病的癌症患者的预后价值：一项系统评价和荟萃分析。
Diabetes Obes Metab. 2014 Aug;16(8):707-10. doi: 10.1111/dom.12267. Epub 2014 Feb 27.
3
Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.二甲双胍与同时患有 2 型糖尿病的癌症患者的生存获益相关：系统评价和荟萃分析。
Oncologist. 2013;18(12):1248-55. doi: 10.1634/theoncologist.2013-0111. Epub 2013 Nov 20.
4
Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.血清 C 肽浓度与糖尿病前期或未诊断糖尿病患者的癌症死亡率风险的关联。
PLoS One. 2013;8(2):e55625. doi: 10.1371/journal.pone.0055625. Epub 2013 Feb 6.
5
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.糖尿病与胰腺癌风险：胰腺癌队列联盟的汇总分析。
Cancer Causes Control. 2013 Jan;24(1):13-25. doi: 10.1007/s10552-012-0078-8. Epub 2012 Oct 31.
6
Diabetes mellitus and cancer risk: review of the epidemiological evidence.糖尿病与癌症风险：流行病学证据综述。
Cancer Sci. 2013 Jan;104(1):9-14. doi: 10.1111/cas.12043. Epub 2012 Dec 6.
7
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.噻唑烷二酮类药物治疗时间延长与膀胱癌风险的关系：一项队列研究。
J Natl Cancer Inst. 2012 Sep 19;104(18):1411-21. doi: 10.1093/jnci/djs328. Epub 2012 Aug 9.
8
Basal insulin and cardiovascular and other outcomes in dysglycemia.基础胰岛素与糖调节受损患者的心血管及其他结局。
N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.
9
The insulin receptor: a new target for cancer therapy.胰岛素受体：癌症治疗的新靶点。
Front Endocrinol (Lausanne). 2011 Dec 6;2:93. doi: 10.3389/fendo.2011.00093. eCollection 2011.
10
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis.二甲双胍和磺酰脲类药物治疗 2 型糖尿病与癌症风险的关系：荟萃分析。
Oncologist. 2012;17(6):813-22. doi: 10.1634/theoncologist.2011-0462. Epub 2012 May 29.
Zotero 插件